Kyle Holen and Herbert Chen, doctors at UW Hospital, are studying an experimental drug that could someday give hope to patients with a rare form of cancer for which existing treatments rarely work.
The drug could treat neuroendocrine tumors, which involve cells that produce insulin, serotonin, thyroid and other hormones.